We are live on
!
Find out more
ECG
EPIQ Capital Group Portfolio holdings
AUM
$383M
1-Year Est. Return
46.87%
This Fund
S&P 500
This Quarter
Est. Return
+59.42%
1 Year Est. Return
+46.87%
3 Year Est. Return
-6.25%
5 Year Est. Return
+38.91%
10 Year Est. Return
–
AUM
$409M
AUM Growth
–
Cap. Flow
+$317M
Cap. Flow
% of AUM
77.54%
Top 10 Holdings %
Top 10 Hldgs %
91.5%
Holding
42
New
42
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quince Therapeutics
QNCX
|
+$94.8M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$38.4M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$35.3M |
| 4 |
Alibaba
BABA
|
+$28.8M |
| 5 |
iShares Gold Trust
IAU
|
+$25.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.15% |
| 2 | Healthcare | 43.75% |
| 3 | Consumer Discretionary | 9.67% |
| 4 | Communication Services | 1.89% |
| 5 | Technology | 0.45% |
Similar funds
BCA
SAM
GJCM
AP
FWM
BW
WWP
CIM
EPIQ Capital Group's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for EPIQ Capital Group, which disclosed 42 positions worth $409M. Its ten largest holdings account for 92% of the portfolio.
Its largest position is Quince Therapeutics: 15,717 shares worth $176M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, followed by Healthcare and Consumer Discretionary.
- EPIQ Capital Group's largest Q4 2019 buy was Quince Therapeutics: 15,717 shares worth $176M.
- EPIQ Capital Group's ten largest holdings make up 92% of its $409M portfolio in Q4 2019.
- EPIQ Capital Group disclosed 42 positions in Q4 2019, its first 13F filing on record.
Based on EPIQ Capital Group's 13F filing for Q4 2019, filed 18 Jun 2020.